gallery
uploads/5731a78801b405731a78801b8e128483.1.jpg
Browse earlier OneSCDvoice reporting with its original publication date and source. Articles keep the URLs they had when first published.
3,376 articlesCurrent news
uploads/5731a78801b405731a78801b8e128483.1.jpg
Happenings
The SCD Policy Forum brings together sickle cell advocates from across the country for a two-day federal advocacy event. This event is hosted by Sick Cells and the Sickle Cell…
services & support
Welcome to the SCD C.A.R.E.S. (Collaboration of Advocates for Research, Education and Science) Consortium! The mission of this initiative is to raise awareness about the…
sickle cell disease · sickle cell · cell disease · sickle · cell · services & support · Clinical Trial Studies · Clinical Trials · How to Participate
Welcome to the Sickle Cell Disease Association of America’s Clinical Trial Finder, created in partnership with Forma Therapeutics. Our Clinical Trial Finder is a centralized…
Videos · Benefits of Trial Participation · Clinical Trial Studies · Clinical Trials
https://www.youtube.com/watch?v=iWqQiJeP5ac
infographics/slides
/sites/default/files/wp-content/uploads/2024/02/H-3734-SCD-Cares-Consortium-Journey-Flier-rev5_HI.png
sickle cell disease · sickle cell · cell disease · sickle · cell · Patient Education · Family Planning · Gene Therapy · Reproductive Health · Reproductive Issues/Complications · Women's Health
As we closed 2023, the Food and Drug Administration (FDA) approved two gene therapies to treat sickle cell disease (SCD). These potential curative therapies include CASGEVY™…
Happenings
SCDAA and MedicAlert Pilot Program Improving quality of life for people with sickle cell disease Sickle Cell Disease Association of America , Inc. (SCDAA) and MedicAlert…
Business
The US Food and Drug Administration (FDA) recently greenlit 2 cell-based gene treatments for sickle cell anemia, including the first therapy involving the genome editing…
Spotlight
On Dec. 8, 2023, the Food and Drug Administration (FDA) approved two cell-based gene therapies for sickle cell disease (SCD), Casgevy from CRISPR/Vertex and Lyfgenia from bluebird…
sickle cell disease · sickle cell · cell disease · sickle · cell · Patient Education · CRISPR · Gene Editing · patient advocacy
Two gene therapies were recently approved by the Food and Drug Administration (FDA) to treat sickle cell disease: Casegevy from CRISPR/Vertex and Lyfgenia from bluebird bio. You…
Videos · Other Complications/Conditions
https://youtu.be/uJ8EgbK0XuA?si=6mhX7d2t1PBfz6La